This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

20 Jul 2011

Novartis Net Profit Jumps in Q2

Novartis has reported its net profits rise 12 percent to $2.7 billion in the second quarter.

Swiss drugmaker Novartis AG has announced its financial results for the second quarter 2011.


Revenues were up 19% in constant currencies (c.c.) for 2Q11 and +16% YTD. Pharma revenues were up 10% (+2% c.c.) to $8.3 billion in 2Q, with recently launched products contributing $2.3 billion (+34% c.c.). Alcon revenues were up 12% (6% c.c.) to $2.6 billion. Sandoz (generic) revenue rose 25% (16% c.c.) to $2.5 billion.


For the YTD, pharma revenues were up 8% (3% c.c.) to $16.0 billion, with $4.3 billion of that coming from recently launched products. Vaccine sales plummeted in both 2Q and YTD, a result of inflated H1N1 revenues from the previous year. Overall sales in emerging markets rose 27% (19% c.c.) to $1.5 billion in 2Q11.

Related News